Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HUK in Acute Ischemic Stroke
NCT03431909Phase 4Completed
- Sponsor
- Xuanwu Hospital
- Start
- Jan 2014
- Primary completion
- Oct 2016
- Modality
- Therapeutic Enzymes
01
Overview
A Phase 4 trial of Human urinary kallidinogenase in ischemic stroke, sponsored by Xuanwu Hospital. Started Jan 2014; status: completed.
02
Drugs
Human urinary kallidinogenase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03431909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431909.